CNS PHARMACEUTICALS INC (CNSP)

US18978H3003 - Common Stock

0.123  +0.01 (+5.22%)

After market: 0.1529 +0.03 (+24.31%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
17.08M18.87M15.27M14.49M9.45M
Research and Development
12.06M14.10M9.30M9.81M5.06M
Selling, General, and Administrative Expenses
5.02M4.77M5.97M4.68M4.39M
Operating Income
-17.08M-18.87M-15.27M-14.49M-9.45M
Interest Income/Expense
24.58K13.88K-10.00K-10.00K0.00
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-17.06M-18.85M-15.27M-14.50M-9.46M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-17.06M-18.85M-15.27M-14.50M-9.46M
EBITDA
-17.08M-18.86M-15.26M-14.48M-9.44M
 
Per Share Data
EPS Diluted Total Ops
-80.15-250.19-11.22-16.47-11.82
Non GAAP EPS
N/AN/AN/A-810.00-855.00
 
Statistics

All data in USD

Charts